Peer Review History

Original SubmissionJuly 8, 2021
Decision Letter - Walid Kamal Abdelbasset, Editor

PONE-D-21-22271

Using data-driven Bayesian Network analysis to explore recovery pathways in people with low back pain receiving individualised physiotherapy or advice

PLOS ONE

Dear Dr. Liew,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript requires a significant amount of improvement in:

Title

1. Title needs to be modified.

2. Kindly frame title such that it is accurate, informative, descriptive, succinct, simple and specific.

3. Kindly avoid the words like

Abstract:

1. Trial design is not mentioned.

2. The background needs to be shortened.

3. Methods section is poorly framed. It has to be re-written.

4. Demographic profile of patients is not mentioned.

Introduction: please follow these steps to have scientific introduction

1. Explain the rationale of the study. Please delete information unrelated to objective so that the section is short and sweet. For example, the first page of introduction may be deleted. Kindly focus on three elements of introduction.

a. What is known about the topic? (Background)

b. What is not known? (The research problem)

c. Why the study was done? (Justification)

2. Objective is not clear as mentioned above.

1. Methods section determines the results. Kindly focus on three basic elements of methods section.

a. How the study was designed?

b. How the study was carried out?

c. How the data were analyzed?

d. Components of methods

i. Study design, setting, sample size

ii. Participant

iii. Intervention/issue of interest (exposure)

iv. Comparison

v. Ethics and end point

vi. Statistical analysis

1. The discussion section needs to be described scientifically. Kindly frame it along the following lines:

i. Main findings of the present study

ii. Comparison with other studies

iii. Implication and explanation of findings

iv. Strengths and limitations need to be clear

v. Conclusion, recommendation and future direction.

Reviewer #2: The authors conduct a Bayesian Network approach to model the recovery pathways in 300 people with low back pain receiving individualized physiotherapy or advice from a randomized controlled trial. The results showed that individualized physiotherapy reduced early improvement in disability and its relevant consequences.

1. Variables included in the Bayesian Network. Was sample characteristic information (e.g. age, sex, and so on) included, either as nodes or adjusted, in the Network construction as these information may play an important role?

2. Please comment on whether the missingness behave differently for the participants in two different groups.

3. Table 2. Correlation was reported. What measure of correlation was reported? If Pearson correlation was reported, were the data normally distributed?

4. Please comment on how the directions were decided. Any potential misspecification or reciprocal relationship? If so, how these may affect the results?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see the uploaded Response to Reviewers document for a proper view of our detailed reply, which includes tables, figures with the appropriate formatting.

Editor

Thank-you for the opportunity to revise our manuscript for PLOS ONE. We have carefully addressed the comments of the editor and the two reviewers, and feel confident that the manuscript has been enhanced by these recommendations.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Reply: We have checked the manuscript against the PLOS ONE style requirements and believe it is compliant.

2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal).

Reply: Further information around consent of participants has been added to the manuscript as per the text below (L97):

All participants provided written informed consent to participate in the trial.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Reply: Participants from the study provided informed consent that their data would only be made available to other researchers on specific request to Dr. Ford or Dr. Hahne. We are therefore unable to publicly publish the dataset from this study, but reasonable requests to access the data can be directed either to the authors, or alternatively to:

Senior Manager, Ethics, Integrity and Biosafety

Human Ethics Committee

La Trobe University

Telephone: +61 3 9479 1443

Email: humanethics@latrobe.edu.au

Quote ethics ID: FHEC08/196

Once again, than-you for the opportunity to revise our paper for PLOS ONE.

Reviewer #1:

This manuscript requires a significant amount of improvement in:

Title

1. Title needs to be modified.

Reply: The title has been completely re-written

Changed from: Using data-driven Bayesian Network analysis to explore recovery pathways in people with low back pain receiving individualised physiotherapy or advice.

Changed to: How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data.

2. Kindly frame title such that it is accurate, informative, descriptive, succinct, simple and specific.

Reply: We thank the Reviewer for this specific suggestion. The new title as presented above has attempted to address these criteria.

3. Kindly avoid the words like

Reply: The comment was incomplete, but as the title has been completely re-written we hope the concern has been addressed.

Abstract:

1. Trial design is not mentioned.

Reply: We thank the Reviewer for this observation. The trial design has been added to the abstract using the following text (L22):

We sought to determine how this treatment works by using randomised controlled trial data to develop a Bayesian Network model.

2. The background needs to be shortened.

Reply: We thank the Reviewer for their suggestion. We have shortened the background in the Abstract to comprise two short sentences as indicated below (L21):

Individualised physiotherapy is an effective treatment for low back pain. We sought to determine how this treatment works by using randomised controlled trial data to develop a Bayesian Network model.

3. Methods section is poorly framed. It has to be re-written.

Reply: We have completely re-structured the methods section of the Abstract to make it clearer, incorporating information on participants, treatments, analysis approach, and what the data is able to explain (L24).

300 randomised controlled trial participants (153 male, 147 female, mean age 44.1) with low back pain (of duration 6-26 weeks) received either individualised physiotherapy or advice. Variables with potential to explain how individualised physiotherapy works were included in a multivariate Bayesian Network model. Modelling incorporated the intervention period (0-10 weeks after study commencement – “early” changes) and the followup period (10-52 weeks after study commencement – “late” changes). Sequences of variables in the Bayesian Network showed the most common direct and indirect recovery pathways followed by participants with low back pain receiving individualised physiotherapy or advice.

4. Demographic profile of patients is not mentioned.

Reply: This has been added to the methods section of the Abstract (L24):

300 randomised controlled trial participants (153 male, 147 female, mean age 44.1) with low back pain (of duration 6-26 weeks)…

Introduction: please follow these steps to have scientific introduction

1. Explain the rationale of the study. Please delete information unrelated to objective so that the section is short and sweet. For example, the first page of introduction may be deleted. Kindly focus on three elements of introduction.

a. What is known about the topic? (Background)

b. What is not known? (The research problem)

c. Why the study was done? (Justification)

Reply: We thank the Reviewer for their helpful suggestions to help focus the structure of our Introduction. We have re-written the Introduction to focus on 1) introducing the topic (how do low back pain treatments work), 2) presenting the limitations of previous research that has tried to answer this question, and establishing what questions remain unanswered, and 3) justification and objectives of the current study.

2. Objective is not clear as mentioned above.

Reply: As part of re-writing the Introduction, the objective of the study is now more clearly stated at the end of the introduction (L88).

The aim of this study was to determine how the individualised physiotherapy (relative to the advice) approach in the STOPS RCT helped people with LBP.

1. Methods section determines the results. Kindly focus on three basic elements of methods section.

a. How the study was designed?

b. How the study was carried out?

c. How the data were analyzed?

d. Components of methods

i. Study design, setting, sample size

ii. Participant

iii. Intervention/issue of interest (exposure)

iv. Comparison

v. Ethics and end point

vi. Statistical analysis

Reply: We thank the Reviewer for their recommendations for important elements to include in the Methods section. We have revised the manuscript to ensure that each suggested element is included. We have also checked recent articles in PLOS ONE to ensure consistency of structure and subheadings. Changes to the manuscript as a result of this restructuring are evident via tracked changes.

1. The discussion section needs to be described scientifically. Kindly frame it along the following lines:

i. Main findings of the present study

ii. Comparison with other studies

iii. Implication and explanation of findings

iv. Strengths and limitations need to be clear

v. Conclusion, recommendation, and future direction.

Reply: We thank the Reviewer again for outlining the important elements for Discussion. We have revised our manuscript to ensure that all suggested elements are addressed. However, given that we discuss three main points a slightly altered structure was chosen to the one suggested by the Reviewer so that each main point could be thoroughly discussed one at a time. The new structure involves:

Paragraph 1 summarises the main findings of the study from the results

Paragraph 2 discusses the first main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 3 discusses the second main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 4 discusses the third main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 5 discusses the strengths of the study

Paragraph 6 discusses the limitations of the study

Paragraph 7 concludes and makes recommendations for future research

We believe this structure flows logically, aligns with the order of the results presented, and is consistent with the structure of other recent articles published in PLOS ONE.

Reviewer #2

The authors conduct a Bayesian Network approach to model the recovery pathways in 300 people with low back pain receiving individualized physiotherapy or advice from a randomized controlled trial. The results showed that individualized physiotherapy reduced early improvement in disability and its relevant consequences.

1. Variables included in the Bayesian Network. Was sample characteristic information (e.g. age, sex, and so on) included, either as nodes or adjusted, in the Network construction as these information may play an important role?

Reply: We only included factors in the Bayesian Network that were potentially modifiable, as this would make them potentially useful therapeutic targets. Sample characteristics at baseline are not modifiable with treatment. In addition, our previous publications on the current data set show that there were no differences between treatment groups on any of the baseline sample characteristic (Ford et al. 2016), nor were these characteristics predictive of outcome (Ford et al 2018). However, we have also included the descriptive statistics of the baseline demographic characteristics in the revised Table 1, in response to the comment below.

We also ran an exploratory Bayesian Network analysis with the four demographic variables included, but found that these variables did not influence other variables (see image below). To create a simpler model, we excluded these four demographic variables during the formal analysis.

2. Please comment on whether the missingness behave differently for the participants in two different groups.

Reply: We thank the Reviewer for this comment. We have included in the revised Table 1, baseline descriptive characteristics for all participants, including the 11 that were excluded due to high missing data.

Table 1.Baseline descriptive characteristics of cohort included in Bayesian Network analysis

Baseline variable Advice (n = 137) Individualized PT (n = 152) Missing-excluded (n = 11) P.value

Age(years) 44.69(12.33) 42.67(12.02) 44.19(11.75) 0.368

Sex-Female* 67 74 6 0.931

Sex-Male* 70 78 5 0.931

Weight(kg) 77.41(15.79) 77.26(17.77) 174.38(6.07) 0.195

Height(cm) 169.97(11.52) 172.24(10.47) 74.7(8.93) 0.885

Disability 29.71(13.25) 29.31(11.85) 26.82(5.78) 0.750

Low back pain intensity 5.48(1.94) 5.29(1.97) 4.77(1.47) 0.415

Leg pain intensity 4.76(2.62) 4.58(2.74) 4.8(2.49) 0.860

Pain coping 5.06(2.15) 5.16(2.37) 4.36(2.38) 0.526

Anxiety 5.08(2.5) 4.62(2.58) 4(3.52) 0.183

Depression 3.54(2.98) 3.01(2.98) 3.64(3.5) 0.312

Pain persistence 7.26(2.17) 6.74(2.36) 6.55(3.17) 0.128

Work expectations 2.01(3.24) 1.63(2.95) 5.36(4.18) 0.001

Sleep 3.69(2.54) 3.57(2.49) 3.45(2.5) 0.893

Fear 18.11(6.01) 18.58(6.17) 22.6(6.13) 0.081

Abbreviations: PT - physiotherapy

* - variables represent counts of participants. All other values reflect mean (one standard deviation).

P values for continuous variables derived from a one-way Analysis of Variance test, count variable from a Chi-squared Test.

3. Table 2. Correlation was reported. What measure of correlation was reported? If Pearson correlation was reported, were the data normally distributed?

Reply: We thank the Reviewer for this comment. Yes, this was the Pearson correlation, and we edited the wording to reflect this change. The assumption of the normal distribution is really important only if the statistical inference of the correlation was undertaken – which we did not in the present project. Furthermore, we confirmed that the reported Pearson correlations are not inflated: both the observed and the predicted values are approximately symmetric and present little in the way of skewness. We also excluded inflation due to outliers by checking a plot of observed values against predicted values. In addition to the correlation values, we have included other traditional metrics of performance in linear regression modelling, such as root-mean-square error, mean square error, and mean absolute error (revised Table 2).

Table 2 Measurement errors between observed and predicted change values

Variable Correlation Correlation strength RMSE MSE MAE

disability_early 0.72 high 9.2 85.4 7.2

lbp_early 0.68 moderate 1.8 3.4 1.4

lp_early 0.71 high 1.9 3.5 1.4

pain_cope_early 0.52 moderate 2.6 7.2 2.1

sleep_early 0.53 moderate 1.9 3.8 1.5

work_expect_early 0.44 low 2.1 4.7 1.6

pain_persist_early 0.62 moderate 2.4 5.9 1.9

anx_early 0.76 high 2.0 4.4 1.2

depress_early 0.69 moderate 2.3 5.4 1.8

fear_early 0.55 moderate 5.7 32.1 4.3

disability_late 0.73 high 8.2 68.8 6.2

lbp_late 0.71 high 1.6 2.5 1.2

lp_late 0.70 moderate 1.7 3.1 1.2

pain_cope_late 0.46 low 2.6 6.8 1.8

sleep_late 0.59 moderate 1.7 3.1 1.2

work_expect_late 0.42 low 1.6 2.7 1.1

pain_persist_late 0.65 moderate 2.6 7.0 1.9

anx_late 0.74 high 1.9 4.0 1.0

depress_late 0.65 moderate 1.7 2.9 1.1

fear_late 0.53 moderate 5.0 25.4 3.8

Abbreviation: Abbreviation: Suffix with “_early” – change score between baseline and week-10 follow-up; “_late” – change value between week-10 and week-52; Anx - anxiety; lbp – low back pain; lp – leg pain; RMSE – root-mean-squared error; MSE- mean squared error; MAE- mean absolute error.

4. Please comment on how the directions were decided. Any potential misspecification or reciprocal relationship? If so, how these may affect the results?

Reply: We thank the Reviewer for this comment. Herein, we use the term “structural learning” to reflect learning the direction of relationships. We used the “hill-climbing” algorithm, which was embedded into structural expectation-maximization for structural learning. The hill-climbing algorithm uses a search strategy that explores the space of the directed acyclic graphs by single-arc addition, removal, and reversals (without introducing cycles into the graph); with random restarts to avoid local optima. The structure that maximizes the model fit to the data is retained.

Reciprocal, bidirectional, relationships are not permitted in a Bayesian Network model, because by definition, a Bayesian Network models an acyclic graph. Bidirectional relationships will introduce cycles into the model, something that is avoided in all structural learning algorithms for Bayesian Network. Note that cyclic and bidirectional/reciprocal relationships are forbidden in the Bayesian networks, in which the same variable is represented by different nodes at different time points; but they can still be read from the network if we consider variables after abstracting away time. For instance, in Figure 2 we can see the arcs anx_early -> depress_late and depress_early -> anx_late: these indicate a feedback loop in which anxiety feeds depression which in turn feeds anxiety.

Misspecification is possible if there are missing confounding variables. We have identified this as a potential study limitation in the Discussion of the Original manuscript. To further mitigate modelling biologically unrealistic relationships (e.g. if a variable at 12th month can influence another variable at baseline), we included a blacklist into the model, so that such relationships are enforced during model building.

Attachments
Attachment
Submitted filename: ReplyReview_R1_v2.docx
Decision Letter - Walid Kamal Abdelbasset, Editor

How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data

PONE-D-21-22271R1

Dear Dr. Liew,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Walid Kamal Abdelbasset, Editor

PONE-D-21-22271R1

How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data.  

Dear Dr. Liew:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Walid Kamal Abdelbasset

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .